FOLH1 and prostate cancer: Previous studies with 68Ga-PSMA-11-PET and 18F-piflufolastat in recurrent prostate cancer have frequently reported a clear association between positive PET scans and various factors such as baseline PSA, PSAdt, Gleason score, and prior treatment.17